Medicus Pharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Equivalents	8.71	4.16	1.72	0.27
Cash & Short-Term Investments	8.71	4.16	1.72	0.27
Cash Growth	109.04%	142.21%	542.38%	-
Other Current Assets	1.19	1.21	0.17	0.02
Total Current Assets	9.89	5.38	1.89	0.28
Net Property, Plant & Equipment	0.17	0.27	-	-
Total Assets	10.06	5.65	1.89	0.28
Accounts Payable	3.55	1.43	0.38	0.1
Accrued Expenses	1	0.76	0.4	-
Short-Term Debt	5.25	-	-	1.53
Current Portion of Leases	0.15	0.12	-	-
Other Current Liabilities	-	-	-	10.85
Total Current Liabilities	9.94	2.31	0.78	12.48
Long-Term Debt	0.03	-	-	-
Long-Term Leases	0.06	0.21	-	-
Total Long-Term Liabilities	0.09	0.21	-	-
Total Liabilities	10.02	2.51	0.78	12.48
Common Stock	57.39	30.52	18.76	-
Additional Paid-in Capital	6.88	1.52	0.1	-
Accumulated Other Comprehensive Income	0.01	-	-	-
Retained Earnings	-64.35	-28.9	-17.75	-12.39
Total Common Shareholders' Equity	-0.07	3.13	1.11	-12.39
Minority Interest	0.1	-	-	-
Shareholders' Equity	0.04	3.13	1.11	-12.2
Total Liabilities & Equity	10.06	5.65	1.89	0.28
Total Debt	5.48	0.32	0	1.53
Net Cash (Debt)	3.23	3.84	1.72	-1.26
Net Cash Growth	-15.98%	123.46%	-	-
Net Cash Per Share	0.19	0.40	0.49	-0.67
Book Value	-0.07	3.13	1.11	-12.39
Book Value Per Share	-0.00	0.33	0.32	-6.57
Tangible Book Value	-0.07	3.13	1.11	-12.39
Tangible Book Value Per Share	-0.00	0.33	0.32	-6.57

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q